Geneos Wealth Management’s Lemonade LMND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-136
Closed -$2.24K – 2592
2024
Q2
$2.24K Buy
136
+1
+0.7% +$17 ﹤0.01% 1868
2024
Q1
$2.21K Sell
135
-550
-80% -$9.25K ﹤0.01% 1883
2023
Q4
$11K Sell
685
-100
-13% -$1.51K ﹤0.01% 1524
2023
Q3
$9.12K Hold
785
– – ﹤0.01% 1596
2023
Q2
$13.2K Buy
785
+300
+62% +$4.69K ﹤0.01% 1493
2023
Q1
$6.92K Sell
485
-289
-37% -$4.39K ﹤0.01% 1647
2022
Q4
$10.6K Sell
774
-786
-50% -$15.5K ﹤0.01% 1518
2022
Q3
$33K Sell
1,560
-2,009
-56% -$45.7K ﹤0.01% 1172
2022
Q2
$66K Buy
3,569
+4
+0.1% +$84 ﹤0.01% 1169
2022
Q1
$94K Buy
3,565
+3,050
+592% +$86.4K ﹤0.01% 1117
2021
Q4
$21K Sell
515
-66
-11% -$3.71K ﹤0.01% 1862
2021
Q3
$37K Sell
581
-705
-55% -$56.8K ﹤0.01% 1633
2021
Q2
$138K Sell
1,286
-166
-11% -$15.1K 0.01% 1024
2021
Q1
$131K Buy
1,452
+120
+9% +$15.5K ﹤0.01% 1173
2020
Q4
$108K Buy
+1,332
New +$98.2K ﹤0.01% 1116

Other funds holding LMND

Geneos Wealth Management's LMND Position: Q3 2024 in Review

Geneos Wealth Management sold out of Lemonade (LMND) in Q3 2024, closing a stake of 136 shares — an estimated $2.24K sold.

Geneos Wealth Management first reported a position in LMND in Q4 2020 and held it in 15 quarters. The position peaked at $138K in Q2 2021. 224 funds tracked by Wall St. Rank hold LMND as of Q3 2024.

  • Geneos Wealth Management reported no remaining Lemonade position as of Q3 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 136 Lemonade shares in Q3 2024, an estimated $2.24K.
  • Geneos Wealth Management first reported a position in Lemonade in Q4 2020 and held it in 15 quarters.
  • Geneos Wealth Management's Lemonade position peaked at $138K in Q2 2021.
  • 224 funds tracked by Wall St. Rank held Lemonade as of Q3 2024.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.